Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from GH Research

GH Research Shares Q2 2022 Financial Results & Business Updates

GH Research PLC (NASDAQ: GHRS), the clinical-stage biopharma company dedicated to transforming the treatment of psychiatric and neurological disorders through 5-MeO-DMT production, provided a financial and business update for the quarter ended June 30, 2022.

Psychedelic Stock Gainers And Losers From June 16, 2022

Psychedelic Stock Gainers And Losers From June 16, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.08% at $10.05 LOSERS:

Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Cybin, GH Research Among Top Psychedelic Movers Of Today

GAINERS: Cybin (AMEX:CYBN) shares closed up 9.50% at $0.75

GH Research, Intelgenx Technologies Among Top Psychedelic Movers Of Today

GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 5.09% at $25.80 LOSERS:

Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 4.78% at $19.73 LOSERS:

Psychedelic Stock Gainers And Losers From March 7, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 1.49% at $15.71 LOSERS:

inkl

Read news from The Economist, FT, and more,
with one subscription

Small Pharma, GH Research Among Top Psychedelic Movers Of Today

Small Pharma, GH Research Among Top Psychedelic Movers Of Today

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.99% at $0.24

Psychedelic Stock Gainers And Losers From January 21, 2022

Psychedelic Stock Gainers And Losers From January 21, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 1.18% at $17.19 LOSERS:

1

Organisations

Sanderson Farms

Republic Services

Field Trip Health

Arthur J Gallagher

Eastman Chemical

TRI Pointe Homes

DuPont de Nemours

Taylor Morrison Home

B.Riley Securities

Intellia rapeutics

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Places

243,153 stories

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play